Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
4-HNE, 4-hydroxynonenal; 8-isoprostane, 8-isoprostaglandin F2α; AGE, advanced glycation end product; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; CAT, catalase; CI, confidence interval; CP, chronic periodontitis; DM, diabetes mellitus; DMCP, diabetes-related periodontitis; Foxp3, forkhead box P3; G-CSF, granulocyte colony-stimulating factor; GIP, glucose-dependent insulinotropic polypeptide; GLP-1, glucagon-like peptide-1; GM-CSF, granulocyte-macrophage colony-stimulating factor; GR, glutathione reductase; GSH, reduced glutathione; GSSG, oxidized glutathione; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; hs-CRP, high-sensitivity C-reactive protein; IFN-γ, interferon-gamma; IL, interleukin; LDL, low-density lipoprotein; MCP-1, monocyte chemoattractant protein-1; MDA, malondialdehyde; MIP-1α, macrophage inflammatory protein-1 alpha; NA, not available; NOS, nitric oxide synthase; OPG, osteoprotegerin; OSI, oxidative stress index; PAI-1, plasminogen activator inhibitor-1; RAGE, receptor for advanced glycation end products; RANKL, receptor activator of nuclear factor-kappa B ligand; ROM, reactive oxygen metabolites; RORC2, RAR-related orphan receptor C2; SCF, stem cell factor; SMAC, second mitochondria-derived activator of caspase; SMD, standardized mean difference; SOD, superoxide dismutase; TAOC, total antioxidant capacity; TC, total cholesterol; TG, triglycerides; TGF-β, transforming growth factor-beta; TIMP, tissue inhibitor of metalloproteinase; TLR, toll-like receptor; TNF-α, tumor necrosis factor-alpha; TOS, total oxidant status; UA, uric acid; VLDL, very low-density lipoprotein; 25(OH)D, 25-hydroxyvitamin D.
Source: Study characteristics. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Systematic review.
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Biomarkers for differentiating diabetic periodontitis from chronic periodontitis: a systematic review and meta-analysis
Source: Article title.
Biomarkers for differentiating diabetic periodontitis from chronic periodontitis: a systematic review and meta-analysis
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Biomarkers for differentiating diabetic periodontitis from chronic periodontitis: a systematic review and meta-analysis
Systematic review · Frontiers in Immunology · 2026
Original publication title
Biomarkers for differentiating diabetic periodontitis from chronic periodontitis: a systematic review and meta-analysis
Copyright © 2026 Zhang, Li, Zhang, Kong, Zhang, Zhang and Sun.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Diabetes-related periodontitis (DMCP) and chronic periodontitis (CP) are associated with significant differences in clinical presentation, pathogenesis, and treatment outcomes. However, reliable biomarkers for their early differentiation remain elusive. This study aims to identify discriminatory biomarkers between DMCP and CP to provide an evidence-based foundation for improved clinical management.
Source: BackgroundAbstract: What methods does the paper describe?
A systematic search of PubMed, Embase, the Cochrane Library, and Web of Science was conducted from their inception until October 2025 for studies comparing biomarkers in DMCP and CP. Differences in biomarker levels between the two groups were expressed as Standardized Mean Differences (SMD) with 95% Confidence Intervals (CI). All meta-analyses were performed using a random-effects model.
Source: MethodsAbstract: Systematic Review Registration
https://inplasy.com/inplasy-2025-11-0067/, identifier INPLASY2025110067.
Source: Systematic Review RegistrationAbstract: Results
A total of 33 eligible studies were included, involving 970 patients with DMCP and 905 with CP. The meta-analysis revealed the following: (1) lipid profiles: the DMCP group demonstrated significantly higher levels of very low-density lipoprotein (VLDL) (SMD: 0.91; 95%CI: 0.43 to 1.39; P<0.001) compared to the CP group; (2) inflammatory factors: levels of interleukin-8 (IL-8) (SMD: 0.38, 95%CI: 0.06 to 0.70; P=0.021), and high-sensitivity C-reactive protein (hs-CRP) (SMD: 2.56; 95%CI: 0.31 to 4.82; P=0.026) were significantly elevated in the DMCP group; (3) oxidative stress-related markers: A significant decrease was observed in catalase (CAT) (SMD: -0.31; 95%CI: -0.58 to -0.05; P=0.021) and oxidized glutathione (GSSG) (SMD: -1.16; 95%CI: -1.76 to -0.55; P < 0.001) in the DMCP group.
Conversely, levels of nitric oxide synthase (NOS) (SMD: 0.58; 95%CI: 0.11 to 1.05; P=.016) and 4-hydroxynonenal (4-HNE) (SMD: 7.05; 95%CI: 5.07 to 9.03; P < 0.001) were markedly higher; and (4) other biomarkers: the DMCP group exhibited significantly elevated levels of body mass index, eotaxin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and plasminogen activator inhibitor-1, alongside significantly reduced levels of C-peptide and 25-hydroxyvitamin D.
Source: ResultsAbstract: Conclusions
Significant differences in biomarkers related to lipid metabolism, inflammatory response, and oxidative stress were observed between patients with DMCP and CP. Key indicators demonstrating relatively robust differences include VLDL, 4-HNE, CAT, GSSG, NOS, IL-8, hs-CRP, and C-peptide.
Source: ConclusionsAuthors’ abstract
Background
Diabetes-related periodontitis (DMCP) and chronic periodontitis (CP) are associated with significant differences in clinical presentation, pathogenesis, and treatment outcomes. However, reliable biomarkers for their early differentiation remain elusive. This study aims to identify discriminatory biomarkers between DMCP and CP to provide an evidence-based foundation for improved clinical management.
Methods
A systematic search of PubMed, Embase, the Cochrane Library, and Web of Science was conducted from their inception until October 2025 for studies comparing biomarkers in DMCP and CP. Differences in biomarker levels between the two groups were expressed as Standardized Mean Differences (SMD) with 95% Confidence Intervals (CI). All meta-analyses were performed using a random-effects model.
Results
A total of 33 eligible studies were included, involving 970 patients with DMCP and 905 with CP. The meta-analysis revealed the following: (1) lipid profiles: the DMCP group demonstrated significantly higher levels of very low-density lipoprotein (VLDL) (SMD: 0.91; 95%CI: 0.43 to 1.39; P<0.001) compared to the CP group; (2) inflammatory factors: levels of interleukin-8 (IL-8) (SMD: 0.38, 95%CI: 0.06 to 0.70; P=0.021), and high-sensitivity C-reactive protein (hs-CRP) (SMD: 2.56; 95%CI: 0.31 to 4.82; P=0.026) were significantly elevated in the DMCP group; (3) oxidative stress-related markers: A significant decrease was observed in catalase (CAT) (SMD: -0.31; 95%CI: -0.58 to -0.05; P=0.021) and oxidized glutathione (GSSG) (SMD: -1.16; 95%CI: -1.76 to -0.55; P < 0.001) in the DMCP group.
Conversely, levels of nitric oxide synthase (NOS) (SMD: 0.58; 95%CI: 0.11 to 1.05; P=.016) and 4-hydroxynonenal (4-HNE) (SMD: 7.05; 95%CI: 5.07 to 9.03; P < 0.001) were markedly higher; and (4) other biomarkers: the DMCP group exhibited significantly elevated levels of body mass index, eotaxin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and plasminogen activator inhibitor-1, alongside significantly reduced levels of C-peptide and 25-hydroxyvitamin D.
Conclusions
Significant differences in biomarkers related to lipid metabolism, inflammatory response, and oxidative stress were observed between patients with DMCP and CP. Key indicators demonstrating relatively robust differences include VLDL, 4-HNE, CAT, GSSG, NOS, IL-8, hs-CRP, and C-peptide.
Systematic Review Registration
https://inplasy.com/inplasy-2025-11-0067/, identifier INPLASY2025110067.
Publication and source details
Original title: Biomarkers for differentiating diabetic periodontitis from chronic periodontitis: a systematic review and meta-analysis
Li Zhang; Ru Li; Shengnan Zhang; Wenhui Kong; Peipei Zhang; Wenyue Zhang; Jing Sun
Frontiers in Immunology · 2026
* Correspondence: Jing Sun, sunjing20250909@163.com†These authors have contributed equally to this work
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:20:05.652407+00:00
DOI: 10.3389/fimmu.2026.1758079 · PMC13290632